U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493759) titled 'Systemic Immune-Inflamation Index and Mortality in ICU Patients' on Feb. 19.
Brief Summary: Systemic Immune-Inflammation Index (SII) is a hemogram-derived biomarker reflecting the balance between systemic inflammation and immune response. In critically ill patients, inflammatory burden at admission may play a key role in prognosis. This retrospective cohort study aims to evaluate the association between admission SII levels and intensive care unit (ICU) mortality in adult patients admitted to a reanimation ICU. Secondary objectives include comparison of mortality according to infectious versus non-infectious admission diagnoses and...